APA Zitierstil

Rudnicki, M. (2017). Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies. Biomed Res Int.

Chicago Zitierstil

Rudnicki, Michael. "Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies." Biomed Res Int 2017.

MLA Zitierstil

Rudnicki, Michael. "Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies." Biomed Res Int 2017.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.